Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 278009Generated: October 26, 2026

5-Trifluoromethanesulfonyloxy-3-(1-methylpiperidin-4-yl)pyrrolo[3,2-b]pyridine → 5-(Benzimidazol-2-yl)-3-(1-Methylpiperidin-4-yl)-4-Aza-1H-Indole

https://huagongshe.com/reaction/278009

Reaction equation

Participants

RoleNameHCIDCharge
Reactant5-Trifluoromethanesulfonyloxy-3-(1-methylpiperidin-4-yl)pyrrolo[3,2-b]pyridineHCID 12041812—
Reactanttert-Butyl 2-chloro-1H-benzo[d]imidazole-1-carboxylateHCID 23441223—
Product5-(Benzimidazol-2-yl)-3-(1-Methylpiperidin-4-yl)-4-Aza-1H-IndoleHCID 9927548—

Reaction Steps

O-Trifluoromethanesulfonyl-3-(1-methylpiperidin-4-yl)-5-hydroxy-4-aza-1H-indole (150 mg, 0.413 mmol) and 1-t-butyloxycarbonyl-2-chlorobenzimidazole (104 mg, 0.413 mmol) were converted to the title compound by the procedure of Example 7 except that after chromatography there was a mixture of protected and de-protected products. Therefore, 80 mg of the mixture was dissolved in 20 mL of dichloromethane and 1 mL of trifluoroacetic acid was added. The mixture was stirred for 2 hours and then taken up in water. The reaction was partitioned between 3 mL of 1N aqueous sodium hydroxide and 3 mL of 3:1 chloroform:isopropanol to give 51.2 mg. (37%). MS(FD) m/e 331.8 (M+).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06358972B1
Source datasetuspto-grants-2002_03
ORD IDord-7ca7e6174b9d48e9861f4047a04ecccc
Source noteuspto-grants-2002_03